Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - Clinigence Holdings, Inc.ex32_2.htm
EX-31.2 - EXHIBIT 31.2 - Clinigence Holdings, Inc.ex31_2.htm
EX-31.1 - EXHIBIT 31.1 - Clinigence Holdings, Inc.ex31_1.htm
10-Q - 10-Q - Clinigence Holdings, Inc.clnh093020form10q.htm

Exhibit 32.1

WRITTEN STATEMENT OF THE CHIEF EXECUTIVE OFFICER
Pursuant to 18 U.S.C. Section 1350
As adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002

 

Solely for the purposes of complying with 18 U.S.C. s.1350 as adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002, I, the undersigned Acting Chief Executive Officer of Clinigence Holdings, Inc.. (the “Company”), hereby certify, based on my knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2020, (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

November 16, 2020 /s/ Lawrence Schimmel 
  Acting Chief Executive Officer